Abstract: Provided are a wavelength selective absorption filter including a resin and the following dye A and dye D, each of which has a main absorption wavelength band in a different wavelength range, in which an absorbance Ab (?) at a wavelength ? nm of this wavelength selective absorption filter satisfies a relationship of the Relational Expression (I) 0.05<Ab (450)/Ab (430)<1.00, as well as a polarizing plate and an organic electroluminescent display device or liquid crystal display device including the wavelength selective absorption filter. The dye A is a dye having a main absorption wavelength band in the wavelength selective absorption filter at a wavelength of 400 to 430 nm. The dye D is a dye having a main absorption wavelength band in the wavelength selective absorption filter at a wavelength of 640 to 730 nm.

Abstract: Provided are a polarizing plate protective film including a resin and a coloring agent having an absorption maximum wavelength in a range of 560 to 620 nm or 460 to 520 nm in an amount of 0.1 parts by mass or more with respect to 100 parts by mass of the resin, in which a film thickness is 1 to 18 ?m, and a moisture content is 0.5% by mass or less, a polarizing plate in which the protective film is used, and a liquid crystal display device in which the polarizing plate is used.

Abstract: Provided are an ultraviolet absorbing agent including a compound represented by Formula (1), in which the ultraviolet absorbing agent has a maximum absorption wavelength in a wavelength range of 350 to 390 nm in an ethyl acetate solution, and a value obtained by dividing an absorbance at a wavelength of 430 nm by an absorbance at the maximum absorption wavelength is 0.01 or less, a resin composition, a cured substance, and an optical member which include the ultraviolet absorbing agent, a method of producing an ultraviolet absorbing agent, and a compound. In Formula (1), X1 and X2 each independently represent a cyano group or the like, R1 and R2 each independently represent an alkyl group or the like, and R3 and R4 each independently represent a hydrogen atom, a halogen atom, an alkyl group, an aryl group, an alkoxy group, or an aryloxy group.

Abstract: Provided are a wavelength selective absorption filter including a resin and the following dye A and dye D, each of which has a main absorption wavelength band in a different wavelength range, in which an absorbance Ab (?) at a wavelength ? nm of this wavelength selective absorption filter satisfies a relationship of the Relational Expression (I) 0.05<Ab (450)/Ab (430)<1.00, as well as a polarizing plate and an organic electroluminescent display device or liquid crystal display device including the wavelength selective absorption filter. The dye A is a dye having a main absorption wavelength band in the wavelength selective absorption filter at a wavelength of 400 to 430 nm. The dye D is a dye having a main absorption wavelength band in the wavelength selective absorption filter at a wavelength of 640 to 730 nm.

Abstract: Provided is a resin composition including a compound represented by Formula (1), and a resin. R1 and R2 in Formula (1) each independently represent an alkyl group or the like, R3 and R6 each independently represent an alkoxy group or the like, R4 represents an alkyl group, an aryl group, an alkoxy group, or an aryloxy group, and R5 represents a hydrogen atom, an alkyl group, an aryl group, an alkoxy group, or an aryloxy group. Provided are a cured substance, an ultraviolet absorbing agent, an ultraviolet cut filter, a lens, a protective material, a compound, and a method of synthesizing a compound.

Abstract: Provided are a resin composition including a coloring agent represented by Formula 1 and a resin; a liquid composition; a coloring agent compound; and an optical material. In Formula 1, R1 and R2 each independently represent an alkyl group or an aryl group, R3, R4, R5, and R6 each independently represent a hydrogen atom or a substituent, and R5 and R6 may be bonded to each other to form a 6-membered ring.

Abstract: Provided are a resin composition including a compound represented by Formula (1) and a resin, an optical filter including the resin composition, a liquid crystal display device and a solid-state imaging element including the optical filter, and a compound suitable as a light absorbing component of the resin composition. In Formula (1), Dye represents a colorant structural part obtained by removing n1 hydrogen atoms from a squarylium compound having a specific structure, Q1 is a structural part including a metallocene structure, and n1 represents an integer of 1 to 6.

Abstract: Provided are a polarizing plate protective film including a resin and a coloring agent having an absorption maximum wavelength in a range of 560 to 620 nm or 460 to 520 nm in an amount of 0.1 parts by mass or more with respect to 100 parts by mass of the resin, in which a film thickness is 1 to 18 ?m, and a moisture content is 0.5% by mass or less, a polarizing plate in which the protective film is used, and a liquid crystal display device in which the polarizing plate is used.

Abstract: A compound represented by Formula [1](in the formula, Z1 represents N, CH, or the like; X1 represents NH or the like; R1 represents a heteroaryl group or the like; each of R2, R3, and R4 represents a hydrogen atom, a halogen atom, an alkoxy group, or the like; and R5 represents a heteroaryl group or the like) or salt thereof.

Abstract: A compound represented by Formula [1] (in the formula, Z1 represents N, CH, or the like; X1 represents NH or the like; R1 represents a heteroaryl group or the like; each of R2, R3, and R4 represents a hydrogen atom, a halogen atom, an alkoxy group, or the like; and R5 represents a heteroaryl group or the like) or salt thereof.

Abstract: The invention relates to compounds of a general formula (I): wherein Ar1 is an optionally-substituted aryl or heteroaromatic group; R1 is an optionally-substituted lower alkyl, lower alkenyl, lower alkynyl or cyclo-lower alkyl group, or is an aryl, aralkyl or heteroaromatic group optionally having a substituent; R2 is a hydrogen atom, a lower alkyl group, a lower alkenyl group or a lower alkynyl group, or is an aryl, aralkyl or heteroaromatic group optionally having a substituent; R3 is a hydrogen atom or a lower alkyl group; R4 is a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkyl group or a group of —N(R1k)R1m; T and U are a nitrogen atom or a methine group, etc. The compounds of the invention have excellent Weel kinase-inhibitory effect and are therefore useful in the field of medicines, especially treatment of various cancers.

Abstract: A 1,5-naphthyridine derivative represented by Formula [1] (in which R1, R2, R3, R4 and R5 represent a hydrogen atom, -L-Z (in which Z represents a non-aromatic heterocyclic group or the like; and L represents a single bond or the like), or the like, R6 represents -L-Z or the like, R7 and R8 represent a hydrogen atom or the like, and Q represents an oxygen atom or the like), or a salt thereof has an excellent inhibitory activity with respect to the PI3K-AKT pathway and the Ras-Raf-MEK-ERK pathway, and is useful for treatments such as prophylactic treatments and therapeutic treatments of diseases in which the PI3K-AKT pathway and the Ras-Raf-MEK-ERK pathway are involved.

Abstract: The invention relates to compounds of a general formula (I): wherein Ar1 is an optionally-substituted aryl or heteroaromatic group; R1 is an optionally-substituted lower alkyl, lower alkenyl, lower alkynyl or cyclo-lower alkyl group, or is an aryl, aralkyl or heteroaromatic group optionally having a substituent; R2 is a hydrogen atom, a lower alkyl group, a lower alkenyl group or a lower alkynyl group, or is an aryl, aralkyl or heteroaromatic group optionally having a substituent; R3 is a hydrogen atom or a lower alkyl group; R4 is a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkyl group or a group of —N(R1k)R1m; T and U are a nitrogen atom or a methine group, etc. The compounds of the invention have excellent Weel kinase-inhibitory effect and are therefore useful in the field of medicines, especially treatment of various cancers.

Abstract: A 1,5-naphthyridine derivative represented by Formula [1] (in which R1, R2, R3, R4 and R5 represent a hydrogen atom, -L-Z (in which Z represents a non-aromatic heterocyclic group or the like; and L represents a single bond or the like), or the like, R6 represents -L-Z or the like, R7 and R8 represent a hydrogen atom or the like, and Q represents an oxygen atom or the like), or a salt thereof has an excellent inhibitory activity with respect to the PI3K-AKT pathway and the Ras-Raf-MEK-ERK pathway, and is useful for treatments such as prophylactic treatments and therapeutic treatments of diseases in which the PI3K-AKT pathway and the Ras-Raf-MEK-ERK pathway are involved.

Abstract: The instant invention provides for substituted [1,2,4]triazolo[4,3-a]-1,5-naphthyridine compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms, preferably Akt1. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity, especially Akt1 by administering the compound to a patient in need of treatment of cancer.

Abstract: The present invention relates to a compound of General Formula (I) below, among others. In the Formula, Ar1 is an optionally substituted aryl or heteroaryl group; R1 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, or an optionally substituted aryl, aralkyl, or heteroaryl group; R2 is an optionally substituted aryl, aralkyl, or heteroaryl group; and R3 is a hydrogen atom or a C1-C6 alkyl group. A compound of the present invention has an excellent Wee1 kinase inhibiting effect, and is therefore useful in the filed of medicine, particularly in various types of cancer therapy.

Abstract: The invention relates to a compound of a general formula (I): wherein A1 and A2 each mean a nitrogen atom or an optionally-substituted methine group; Ring B means a 5-membered to 7-membered aliphatic ring, or a spiro or bicyclo ring formed from the aliphatic ring and any other 3-membered to 7-membered aliphatic ring; R1 means a hydrogen atom, or an optionally-substituted C1-C6 alkyl group, or an optionally-substituted aryl, aralkyl or heteroaryl group; R2 means an optionally-substituted aryl, aralkyl or heteroaryl group; and X means a group of ?NH or ?O, etc. Based on its excellent Wee1 kinase-inhibitory effect, the compound of the invention has cell growth-inhibitory effect and has an additive/synergistic effect with any other anticancer agent, and is therefore useful in the field of medicine.

Abstract: The invention relates to compounds of general formula (I-0): wherein R1, R2, R3, R4, R5, R6, R7a, R8a, X, and Y are as defined herein. Compounds of the invention have, based on excellent Wee1 kinase-inhibitory effect, a cell growth-inhibitory effect and an additive/synergistic effect with any other anticancer agent, and are therefore useful in the field of medicine.

Abstract: The compounds of Formula D are of the class of triazolo-pyrido-pyrazines which are inhibitors of AKT useful for the treatment of cancer

Abstract: The present invention relates to a compound of General Formula (I) below, among others. In the Formula, Ar1 is an optionally substituted aryl or heteroaryl group; R1 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, or an optionally substituted aryl, aralkyl, or heteroaryl group; R2 is an optionally substituted aryl, aralkyl, or heteroaryl group; and R3 is a hydrogen atom or a C1-C6 alkyl group. A compound of the present invention has an excellent Weel kinase inhibiting effect, and is therefore useful in the filed of medicine, particularly in various types of cancer therapy.